SCHEMBL30906499

CC[C@H](C)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.57

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.51

▸	NPY4R	P50391	8/20	0.51

▸	NPY5R	Q15761	8/20	0.51

▸	NPY1R	P25929	6/20	0.51

▸	CALCR	P30988	9/20	0.51

▸	EP300	Q09472	1/20	0.50

▸	HIF1A	Q16665	1/20	0.50

▸	RAMP3	O60896	5/20	0.50

▸	CRHR1	P34998	1/20	0.47

▸	CRHR2	Q13324	1/20	0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906450	0.91	RAMP3 (0.52)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL31000891	0.90	CALCR (0.57)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30906475	0.90	RAMP3 (0.53)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30906387	0.90	RAMP3 (0.54)	CALCRRAMP3
SCHEMBL31182476	0.90	EP300 (0.53)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30906512	0.89	CALCR (0.53)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30726569	0.88	RAMP3 (0.63)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30906384	0.88	CALCR (0.49)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL30906398	0.88	CALCR (0.49)	NPY2RNPY4RNPY5RNPY1RCALCR
SCHEMBL9058995	0.88	RAMP3 (0.56)	NPY2RNPY4RNPY5RNPY1RCALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed